Startup regulatory risks overlooked by early-stage investors

Early-stage investors frequently identify regulatory hurdles too late in a company's lifecycle, potentially causing significant delays or deal failures. This oversight is a common issue that both startup founders and the investment community are surprisingly blind to.

Startup culture often emphasizes testing a product based on user feedback but overlooks whether the product itself is legally permissible within its industry. Industry-specific regulations, common in sectors like health and finance, may only surface much later, making them costly to address retroactively.

Investors' due diligence processes tend to focus on market size and unit economics, neglecting actual regulatory readiness. This is often due to "proxy due diligence," where investors assume other participants have already conducted thorough checks.

The legal codification of "Privacy by Design" has shifted how industries manage risks. Similar to privacy concerns previously, regulatory compliance is emerging as a significant issue that is not yet being designed for proactively.

Founders are encouraged to ask key questions during early product development: What is the core regulatory assumption of the business model, who can validate it, and can it be tested alongside the technical build?